+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Function Tests Market by Product, by End-user, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717265
The kidney function tests market size is estimated to be USD 898.2 million in 2022 and is expected to witness a CAGR of 6.91% during the forecast period 2023-2033. The soaring government initiatives, increasing R&D activities, high prevalence of kidney diseases, and technological developments are some of the factors projected to drive the market growth in near future. Furthermore, rising incidence of chronic kidney disease and surge in knowledge of diagnostic techniques for kidney function are other factors supporting the market growth. However, high price of diagnostic methods and stringent regulations are predicted to limit market growth.

Technological developments in renal function tests are expected to fuel the market growth during the projected period. For instance, Nova Biomedical introduced advanced technology in March 2022 to promote kidney treatment by early diagnosis of the disease and renal function testing in POCT settings outside of the hospital. The technology of the company has been validated in clinical studies conducted in a variety of non-hospital settings, including community health centres, pharmacies, imaging facilities, doctor's offices, clinics, and individual home testing.

Rising usage of digital urinalysis is predicted to propel the market growth during the forecast period. A digital health start-up with its headquarters in Israel named Healthy.io anticipated the trend and created an FDA-approved at-home smartphone urine test to assist those looking for kidney tests for proteins. Kidney disease problems can be avoided with early identification. The company's urine test, termed Dip.io, combines disposable cups and test strips with a smartphone camera to read and interpret findings. Additionally, Geisinger Health and NKF studied the test, and they found that it had a 71% adherence rate among hypertension patients who had never been tested before. The start-up is also driven by the quickly developing smartphone industry.

Segmentation

By Product

The market is categorized into dilution and concentration tests, blood tests, clearance tests, urine tests, and other tests. In 2022, the clearance tests segment accounted for the highest revenue share due to the fact that gold standard for tracking and calculating glomerular filtration rate is clearance testing. These items contain tests for creatinine and inulin, which are crucial supplements to conventional diagnostic procedures in order to get accurate results. Additionally, these tests' best sensitivity and precision guarantee that there is minimal variation in performance. These products' low prices and simple accessibility on the market promote better usage. The urine testing market is anticipated to grow significantly during the forecast year. Urea measurement is one of the most popular methods for evaluating renal function. Clinical tests that are essential for identifying renal disease and dysfunction include studies of urine, plasma, and serum urea. Urine tests are usually conducted in conjunction with creatinine determination tests to diagnose pre-renal, renal, and post-renal uremia. Additionally, increasing industry investments are also predicted to drive market expansion for renal function testing. For instance, Sweden-based Elypta AB raised USD 7.0 million in seed funding in January 2020 to develop the first urine test for kidney cancer.

By End User

The market is categorized into research laboratories and institutes, hospitals, diagnostic laboratories, others. In the global market, the hospitals segment accounted for the largest revenue share in 2022 owing to increase in hospitalizations. Hospitals usually have their own diagnostic setup since diagnostic centres work in conjunction with hospitals. Additionally, as healthcare infrastructure continues to advance, existing hospital facilities will likely be improved, adding to their capabilities. As a result, this development can increase the demand for products including renal function tests, pushing the market. Additionally, attractive reimbursement scenarios and an increase in the number of global programmes being launched by healthcare organizations to promote the adoption of advanced diagnostic tests are also projected to fuel industry expansion. The diagnostic laboratories category is predicted to develop the fastest. Some of the main drivers anticipated to spur segment expansion include the expansion in CKD awareness, increase in demand for affordable services, and swift technical advancements. Another significant reason that is projected to propel the market is the rising number of initiatives done by governments to give significant amenities, such as reimbursement for diagnostic tests.

Regional Markets

In 2022, North America region accounted for the highest revenue in the kidney function tests market and is expected to maintain its dominance during the forecast period. This is attributed to strong healthcare infrastructure, widespread knowledge of CKD, advantageous payment regulations, and active government programmes. Additionally, the region's big manufacturers are concentrating on creating advanced products. For instance, Abbott HealthTab, Inc. and Abbott signed a non-assignable, pilot supplier distribution agreement for the i-STAT Alinity, a handheld blood chemistry analyzer, in November 2021. In order to provide patients with critical knowledge regarding their kidney functions, the agreement enables HealthTab to offer Abbott's POC i-STAT Alinity and its associated tests for creatinine in Canadian drug stores. Asia Pacific is predicted to see a substantial CAGR during the forecast period due to increasing prevalence of kidney disease in the region. For instance, according to the Australian Institute of Health and Welfare, around 17,700 people would die from CKD in 2020. In Australia, CKD is to responsible for about 11% of fatalities. Furthermore, a number of CKD awareness campaigns have been launched in countries such as China and Japan, which will probably support the kidney function tests market expand throughout the course of the projection year.

Competitor Insights

Some of the key players operating in the kidney function tests market are Nova Biomedical Corporation, Abbott, Danaher, Sysmex Corporation, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Quest Diagnostics, Randox Laboratories Ltd, and Laboratory Corporation of America Holdings.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Nova Biomedical introduced advanced technology in March 2022 to promote renal treatment through kidney function testing and the identification of kidney disease in POC settings outside of the hospital. In addition, HealthTab, Inc. and Abbott signed a non-assignable and pilot supplier distribution agreement for the handheld blood chemistry analyzer i-STAT Alinity in November 2021.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and end user from 2022 to 2033.

Segmentation: Kidney Function Tests Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Dilution and Concentration Tests
  • Blood Tests
  • Clearance Tests
  • Urine Tests
  • Other Tests

End user (Revenue, USD Million), 2022 - 2033

  • Research Laboratories and Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Kidney Function Tests

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Kidney Function Tests Market

7. Market Analysis by Product
7.1. Dilution and Concentration Tests
7.1.1. Dilution and Concentration Tests Market Forecast, 2022-2033 (USD Million)
7.2. Blood Tests
7.2.1. Blood Tests Market Forecast, 2022-2033 (USD Million)
7.3. Clearance Tests
7.3.1. Clearance Tests Market Forecast, 2022-2033 (USD Million)
7.4. Urine Tests
7.4.1. Urine Tests Market Forecast, 2022-2033 (USD Million)
7.5. Other Tests
7.5.1. Other Tests Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by End User
8.1. Research Laboratories and Institutes
8.1.1. Research Laboratories and Institutes Market Forecast, 2022-2033 (USD Million)
8.2. Hospitals
8.2.1. Hospitals Market Forecast, 2022-2033 (USD Million)
8.3. Diagnostic Laboratories
8.3.1. Diagnostic Laboratories Market Forecast, 2022-2033 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends

9. North America Kidney Function Tests Market
9.1. North America Kidney Function Tests Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.2. U.S. Kidney Function Tests Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.3. Canada Kidney Function Tests Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

10. Europe Kidney Function Tests Market
10.1. Europe Kidney Function Tests Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.2. Germany Kidney Function Tests Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.3. UK Kidney Function Tests Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.4. France Kidney Function Tests Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.5. Spain Kidney Function Tests Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.6. Italy Kidney Function Tests Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.7. Rest of Europe Kidney Function Tests Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

11. Asia Pacific Kidney Function Tests Market
11.1. Asia Pacific Kidney Function Tests Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. Japan Kidney Function Tests Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. China Kidney Function Tests Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.4. India Kidney Function Tests Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5. South Korea Kidney Function Tests Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
11.6. Australia Kidney Function Tests Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Kidney Function Tests Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Latin America Kidney Function Tests Market
12.1. Latin America Kidney Function Tests Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Brazil Kidney Function Tests Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. Mexico Kidney Function Tests Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. Argentina Kidney Function Tests Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. Rest of Latin America Kidney Function Tests Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. MEA Kidney Function Tests Market
13.1. MEA Kidney Function Tests Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. GCC Kidney Function Tests Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. South Africa Kidney Function Tests Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. Rest of MEA Kidney Function Tests Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. Nova Biomedical Corporation
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Abbott
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Danaher
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Sysmex Corporation
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Siemens Healthineers
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. F. Hoffmann-La Roche Ltd.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Quest Diagnostics
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Randox Laboratories Ltd
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Laboratory Corporation of America Holdings
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Company 10
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Product Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players

16. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Nova Biomedical Corporation
  • Abbott
  • Danaher
  • Sysmex Corporation
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics
  • Randox Laboratories Ltd
  • Laboratory Corporation of America Holdings.